|
|
||||||||
1Laboratorio de Microbiología, Instituto Colombiano de Medicina Tropical, Cra 43a No. 52 Sur 99, Sabaneta, Colombia 2Facultad de Medicina Universidad de Antioquia Programa de Maestría Ciencias Básicas Biomédicas, Colombia 3Instituto de Ciencias de la Salud CES, Medellín, Colombia
Correspondence Nora Cardona-Castro ncardona{at}ces.edu.co
Received February 9, 2004
Accepted May 6, 2004
Validation of a PCR test to detect hilA gene sequences of Salmonella spp. was performed in blood and faeces samples from typhoid fever and salmonellosis patients. Sensitivity (S), specificity (SP), positive predictive value (PPV) and negative predictive value (NPV) of the PCR in blood samples were performed by testing: 37 patients with clinical diagnosis of typhoid fever, 34 of them confirmed by isolation of S. Typhi from blood cultures; 35 patients infected with other pathogens corroborated by blood culture (Klebsiella pneumoniae, 9; Serratia marcescens, 5; Escherichia coli, 4; Pseudomonas aeruginosa, 9; Providencia alcalifaciens, 4 and Enterobacter cloacae, 4) and blood samples from 150 healthy volunteers. To evaluate S, SP, PPV and NPV of the PCR in faeces samples we studied: 34 patients with enteritis due Salmonella spp. (S. Typhimurium, 21; S. Enteritidis, 9; S. Choleraesuis, 3 and S. Agona, 1); faeces samples from 35 patients with enteric infection due to Shigella sonnei (8), Shigella flexneri (10), enteropathogenic E. coli (12), Aeromonas hydrophila (5) and faeces samples from 150 healthy volunteers. The S, SP, PPV and NPV of the PCR in blood samples were all 100 %. PCR detected three patients with clinical diagnosis of typhoid fever and negative blood cultures. In faeces samples, S was 97 %, SP 100 %, PPV 100 % and NPV 99 %. The lowest number of c.f.u. ml1 detected by PCR in blood samples was 1x101 and in faeces samples 4x102.
| Introduction |
|---|
|
|
|---|
The development of molecular methods for diagnosis of infectious diseases has improved the sensitivity, specificity, quality and availability of diagnosis and treatment. We developed a PCR test to detect hilA, a regulatory gene found in pathogenicity island 1 of Salmonella spp. hilA is important for the regulation of the type III secretion apparatus, which is involved in the invasion of enterocytes (Lostroh et al., 2000; Mirold et al., 2001). hilA was detected by PCR and hybridization techniques in Salmonella enterica serovars Typhi, Pullorum, Choleraesuis, Enteritidis, Typhimurium (Cardona-Castro et al., 2002), Montevideo (Guo et al., 2000), and is not present in other bacteria (Pathmanathan et al., 2003).
| Methods |
|---|
|
|
|---|
Sensitivity (S), specificity (SP), positive predictive value (PPV) and negative predictive value (NPV) were calculated using Baye's Theorem (Jekel et al., 1996). Briefly, three categories of patients were studied: (i) a true-positive patients group composed of 37 patients with clinical diagnosis of typhoid fever, 34 of them confirmed by isolation of S. Typhi from blood culture, and 34 patients with diarrhoea due to non-Typhi Salmonella isolated by faeces culture (S. Typhimurium, 21; S. Enteritidis, 9; S. Choleraesuis, 3; S. Agona, 1); (ii) a false-positive patients group with non-Salmonella-infected patients with similar symptoms, composed of 35 patients with other bacterial infection confirmed by isolation from blood culture (Klebsiella pneumoniae, 9; Serratia marcescens, 5; E. coli, 4; Pseudomonas aeruginosa, 9; Providencia alcalifaciens, 4 and Enterobacter cloacae, 4), 35 patients with diarrhoea due to other bacteria confirmed by faeces culture (Shigella sonnei, 8; Shigella flexneri, 10; enteropathogenic E. coli, 12 and Aeromonas hydrophila, 5) and (iii) a negative group with 150 blood and 150 faeces samples from healthy people. The gold standard tests to compare the performance of the PCR method were blood and faeces cultures.
Patients.
Volunteer patients of any age or sex, admitted with clinical suspicion of typhoid fever or diarrhoea, during the years 20012003, were included in the present study until the sample size was complete. The patients were admitted at several hospitals of the region and Instituto Colombiano de Medicina Tropical. Every patient, or tutor in the case of children, signed an informed consent. On the day of admittance, blood from typhoid-fever-suspected patients and faeces samples from patients with diarrhoea were taken to perform cultures and PCR detection at the same time.
Blood cultures.
Triplicate blood cultures were performed for each patient with 15 min or more between each testing. A proportion of 1 : 10 sample/broth was inoculated in trypticase soy (Becton Dickinson) and 0.05 % SPS (sodium polyanethole sulfonate) anticoagulant. Blood cultures were incubated at 37 °C; inspection of bottles for turbidity, haemolysis, clotting or gas formation was made for at least 7 days. Gram's staining reaction was done for blood cultures suspected of being positive. According to morphology and Gram reaction, subcultures were performed as recommended by Isenberg (1992).
Faeces cultures.
Faeces samples were collected in a sterile screw-cap cup. Direct examination of fresh stool was done to observe parasites, PMN and erythrocytes. Faeces were inoculated in selenite F broth (Becton Dickinson) at 37 °C for 12 h. Cultures in sorbitol MacConkey and Deoxycholate agar (Becton Dickinson) were performed (Isenberg, 1992).
Bacterial identification.
Biochemical identification for Gram-negative bacilli was done using API 20E (bioMérieux). Serological identification of Salmonella spp. was performed at Instituto Nacional de Salud, Bogotá, Colombia.
Inoculation of blood and faeces samples.
To determine the number of c.f.u. ml1 that the PCR method could detect, 10 blood and 10 faeces samples from healthy volunteers were inoculated with standardized inocula. S. Typhi S008 and S. Typhimurium ICMT02, were used to inoculate blood and faeces samples, respectively. One colony of an overnight culture of the bacteria on nutritive agar was inoculated in 1 ml of BHI (Becton Dickinson) and incubated at 37 °C for 2 h, it was then diluted 1 : 10 in 0.85 % saline solution. Absorbance of the dilution was measured at 640 nm, this reading became the basis for reproducing the inocula later. Serial dilutions of the 1 : 10 inocula were made up to 1 : 108, the number of c.f.u. ml1 per dilution was determined on nutrient agar (Becton Dickinson). This procedure was carried out each time the inocula were prepared. Five millilitres of fresh blood sample was inoculated with 1 ml of each dilution of S. Typhi inocula; 1 g of fresh faeces sample was inoculated with 1 ml of each dilution of S. Typhimurium inocula.
DNA extraction.
Salmonella DNA from both clinical blood and artificially inoculated blood samples was obtained using the modified protocol of lysis buffer proposed by Haque et al. (1999). Briefly, 1 ml of blood sample was centrifuged at 10 000 r.p.m. for 5 min. The pellet was mixed with 1 ml 10 mM Tris/HCl, pH 8, 1 mM EDTA, 0.2 % Triton X-100 and centrifuged at 12 000 r.p.m. for 6 min, this procedure was performed twice. After the second time, the pellet was mixed with 1 ml distilled water and centrifuged for 1 min at 12 000 r.p.m., 30 µl distilled water was added to the pellet followed by incubation at 100 °C for 20 min. The sample was left at 4 °C before PCR.
Extraction of the bacterial DNA from both patient and artificial faeces samples was performed according to the method described by Frankel et al. (1990). A swab of patient faeces samples and 0.5 ml of artificial inoculated faeces sample was mixed with 4 ml PBS, pH 7.4, and then left for 1530 min for the solid components to sediment; 1 ml of the supernatant was centrifuged at 16 000 g for 2 min. The pellet was mixed with 75 µl 50 mM Tris/HCl, pH 8.0, 20 % (w/v) sucrose, 50 mM EDTA and 100 µl 100 µg lysozyme ml1, then incubated at 37 °C for 30 min. A 300 µl volume of 50 mM NaCl, 1 % (w/v) SDS and 100 µl 800 µg proteinase K ml1 was added followed by incubation at 37 °C for 60 min. The mixture was centrifuged at 14 000 g for 5 min. A 300 µl aliquot of the supernatant was taken. DNA was precipitated with absolute ethanol and centrifugation at 16 000 g for 1 min. The pellet was diluted in 500 µl Tris/EDTA (10 mM Tris/HCl, pH 8, 1 mM EDTA), before PCR.
Primers.
The primers were designed according to the hilA gene sequence found at GenomeNet (www.genome.ad.jp), accession number U25352: US: 5'-GCATGGATCCCCGCCGGCGAGATTGTG-3'; DS: 5'-CGGAACGTTATTTGCGCCATGCTGAGGTAG-3'.
PCR protocol.
The same protocol of amplification was used for PCR of blood and faeces samples. A 50 µl reaction volume was used, containing 1.5 µl each primer at 20 µM, 10 µl DNA, 3 µl 0.5 U Taq polymerase µl1 (Promega), 5 µl 10x buffer (Promega), 6 µl 20 mM MgCl2, 0.1 µl each deoxynucleoside triphosphate at 20 µM (Promega) and 22.6 µl distilled water to complete the reaction volume.
PCR was performed in a programmable thermal controller (PTC-100; MJ Research). Parameters for amplification were as follows: initial denaturation at 94 °C for 3 min, 30 cycles of 1 min each at 94 °C, 65 °C and 72 °C and a final extension step at 72 °C for 10 min. PCR amplicons were electrophoresed in a 2 % agarose gel. After staining with ethidium bromide, the amplified fragments in the gel were visualized. The molecular mass marker used was
X174 DNA/HaeIII markers (Promega). PCR was carried out in duplicate for each sample. One positive control (DNA from S. Typhimurium) and two negative controls (one without DNA and the other with DNA from a clinical isolate of E. coli) were included. A product of 854 bp was considered the hilA gene.
| Results and Discussion |
|---|
|
|
|---|
|
|
|
Several PCR methods to detect Salmonella spp. in food and human samples have been developed with the aim of improving diagnosis of the infection. Carli et al. (2001) used a combination of tetrathionate broth enrichment, capillary PCR and gel electrophoresis to detect Salmonella in chicken faeces. Chiu & Ou (1996) detected Salmonella in faeces using the virulence genes invA and spvC as targets for an enrichment broth culture-multiplex PCR. Most methods have been directed against all Salmonella, but Haque et al. (1999) developed their nested PCR method specifically to detect S. Typhi.
Guo et al. (2000) developed a PCR to detect S. Montevideo in artificially infected tomatoes after enrichment, using two pairs of primers to amplify the hilA gene, as used in the current study. The HILA1 pair used by Guo et al. (2000) produced a PCR amplicon of 972 bp, but yielded non-specific bands with Yersinia enterocolitica; the HILA2 pair gave a PCR amplicon of 497 bp. Compared to the current study, the PCR method of Guo et al. (2000) thus uses combined techniques that increase both time and cost for the laboratory.
The PCR method in the current assay used a pair of primers that were originally designed with the intention of detecting the hilA gene in Salmonella species that are clinically important for humans (Cardona-Castro et al., 2002). The forward primer contains a BamHI site and has 17 nucleotides that match the hilA gene sequence exactly. The reverse primer contains a HindIII site and 21 nucleotides match the hilA gene sequence exactly. The method is specific for Salmonella, simple and rapid; it does not use combined techniques, nor does it require enrichment culture before use and does not use a second amplification or nested PCR, taking less time and being cheaper.
According to the results, the current PCR method was more sensitive than blood culture, as it produced a positive test result from three patients with clinical diagnoses of typhoid fever, but with negative culture results; two of the patients had received antibiotic therapy before hospital admittance (Table 1). The results show that PCR methods can be an alternative tool to confirm clinical diagnosis in patients.
Inter-laboratory testing of methods to study the accuracy and robustness of PCR-based methods is an important step towards standardization and approval of the methods (Malorny et al., 2003). The current PCR method was tested in Malaysia, and showed good performance (Pathmanathan et al., 2003). However, the involvement of other endemic regions in testing the method is necessary to evaluate its use in clinical laboratories, and should be a future priority. Hoorfar et al. (2003) recommend the use of an internal amplification control (IAC) in order to improve the standardization of non-commercial PCRs and be confident that negative results are not false-negatives. The current study lacked an IAC, and theoretically, negative test results, e.g. from the negative patient group, could be false-negative. The method showed only one negative test among the positive samples, a faeces sample from a Salmonella-positive patient, possibly because of inhibitory substances in the sample. However, the good performance on positive blood and faeces samples, and the specificity of the PCR primers reported based on testing of other Enterobacteriaceae (Pathmanathan et al., 2003), indicate that the method has the required characteristics with regard to specificity and sensitivity. Future studies of application using this PCR method must include an IAC in order to improve standardization.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |